Webcasts
We are dedicated to creating thought-leading forums to share and connect. Watch one of our webcasts to gain insights on the industry’s hottest topics.
March 2023
Beyond the Script: Brighter Together
October 2022
Complying with the Consolidated Appropriations Act Section 204
September 2022
Analytics and Insights Driving Outcomes
March 2022
Psychedelics Meet Mainstream Medicine
November 2021
A Focus on Alzheimer's Treatment
** See note about FDA Accelerated Approval at the bottom of this page.
September 2021
Taking action to prevent suicide
July 21, 2021
Children and the COVID-19 Vaccine
March 2, 2021
COVID-19: The Road to Immunity
December 2020
Emotional Wellness during COVID-19 & the Holidays
April 2020
Medical Pharmacy Trend Report Webcast
February 2020
Cracking Peanut Allergies
December 2019
Optimizing Health Outcomes Through Member Engagement
November 2019
Clinical Connections: Diabetes & Oral Semaglutide
September 2019
2019 Magellan Rx Management Medicaid Trend Report Webinar
August 2019
Clinical Connections: A Journey Through Zolgensma
April 2019
Medical Pharmacy Trends & Forecasting: Oncology
April 4, 2019
Clinical Connections: Precision Medicine in Oncology
March 2019
2018 Medical Pharmacy Trend Report
January 8, 2019
Clinical Connections: Hemlibra & Hemophilia
October 15, 2018
MRx Predict: Identifying Tomorrow's Challenges Today
October 2, 2018
2018 Medicaid Pharmacy Trend Report
August 27, 2018
Live Vibrantly: Diabetes Management
August 14, 2018
Uncover What is Driving Pharmacy Spending
May 7, 2018
Our Approach to the Opioid Epidemic
April 17, 2018
Digital Therapeutics – the Future of Healthcare is Here
March 28, 2018
Magellan Method: Creating Partnerships That Transform Care
February 6, 2018
Clinical Strategies for Star Rating: Staying Ahead of a Moving Target
November 15, 2017
CAR-T: A New Clinical Frontier
October 25, 2017
MRx Pipeline - October 2017
September 27, 2017
Trends in the Medicaid Market
June 15, 2017
Medical Pharmacy Trend Report for Employers
May 3, 2017
MRx Pipeline - April 2017
**Accelerated Approval is a type of FDA expedited review pathway. It allows for earlier approval of drugs that treat serious conditions, and that fill an unmet medical need based on a surrogate endpoint that is reasonably likely to predict clinical outcomes. A surrogate endpoint is a marker that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. Subsequent confirmatory trials to confirm the clinical benefit must be conducted to support traditional full approval.
